MAF/IgH (MM) Test

Introduction

The MAF/IgH (MM) test is an essential diagnostic procedure utilized in the field of oncology, specifically designed to identify genetic abnormalities linked to multiple myeloma. This test plays a significant role in the early detection and management of this complex disease, allowing healthcare providers to tailor treatment strategies effectively.

What the Test Measures

This test specifically measures the presence of genetic abnormalities associated with multiple myeloma. By utilizing the FISH (Fluorescence In Situ Hybridization) method, it detects chromosomal alterations that can indicate the presence of malignancies in the bone marrow or peripheral blood.

Who Should Consider This Test

Individuals who may benefit from the MAF/IgH (MM) test include:

• Patients exhibiting symptoms such as unexplained bone pain, fatigue, or recurrent infections.
• Individuals with risk factors such as a family history of multiple myeloma or other hematological disorders.
• Patients undergoing treatment for multiple myeloma who need to monitor genetic changes.

Benefits of Taking the Test

The MAF/IgH (MM) test offers several benefits, including:

• Early detection of genetic abnormalities, leading to timely intervention.
• Informed treatment decisions based on the genetic profile of the disease.
• Monitoring disease progression and response to therapy.

Understanding Your Results

Results from the MAF/IgH (MM) test will provide insight into the genetic status of your condition. A healthcare provider will discuss the implications of the findings, helping you understand the next steps in your treatment plan.

Test Pricing

Booking the Test

The MAF/IgH (MM) test requires a doctor’s prescription, except for cases involving surgery, pregnancy, or travel abroad. To schedule your appointment, please call or WhatsApp us at +2348077798758. Our team is ready to assist you with the booking process.

Don’t wait for symptoms to worsen; take charge of your health today with the MAF/IgH (MM) test!